1.
J Investig Allergol Clin Immunol
; 30(6): 470-472, 2020.
Article
in English
| MEDLINE
| ID: mdl-32490823
Subject(s)
Anti-Asthmatic Agents/therapeutic use , Nasal Polyps/drug therapy , Omalizumab/therapeutic use , Anti-Asthmatic Agents/administration & dosage , Asthma/complications , Asthma/diagnosis , Clinical Decision-Making , Disease Management , Humans , Nasal Polyps/diagnosis , Nasal Polyps/etiology , Omalizumab/administration & dosage , Severity of Illness Index , Treatment Outcome
2.
J. investig. allergol. clin. immunol
; 30(6): 470-472, 2020. tab
Article
in English
| IBECS
| ID: ibc-202606
ABSTRACT
No disponible